Literature DB >> 15269453

Genetic analysis of the diversity in Toxoplasma gondii.

Marie-Laure Dardé1.   

Abstract

More than 50 different genetic markers are now available for Toxoplasma gondii isolate typing. For most of them, allelic polymorphism is low (2 to 4 alleles). A few markers, more polymorphic, can be used to fingerprint isolates for epidemiological studies. Phylogenetic analysis detects 2 main groups in Toxoplasma population. Group 2 is genetically heterogeneous. From a practical point of view, 3 main types (types I, II and III) are usually considered. Multilocus genotyping is necessary to reveal atypical or recombinant genotypes, more frequent among isolates collected in remote areas or in wild game. Toxoplasma isolates from human toxoplasmosis are mainly from type II (whatever the severity of clinical disease), but type I and atypical genotypes are found only in severe cases of human toxoplasmosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15269453

Source DB:  PubMed          Journal:  Ann Ist Super Sanita        ISSN: 0021-2571            Impact factor:   1.663


  22 in total

1.  Differential gene expression in mice infected with distinct Toxoplasma strains.

Authors:  Rachel D Hill; Julia S Gouffon; Arnold M Saxton; Chunlei Su
Journal:  Infect Immun       Date:  2011-12-05       Impact factor: 3.441

2.  A new perspective on and re-assessment of SAG2 locus as the tool for genetic analysis of Toxoplasma gondii isolates.

Authors:  A Fazaeli; A Ebrahimzadeh
Journal:  Parasitol Res       Date:  2007-02-13       Impact factor: 2.289

3.  Toxoplasma genotyping in congenital toxoplasmosis in Upper Egypt: evidence of type I strain.

Authors:  Hanan E M Eldeek; Alzahraa Abdel Raouf Ahmad; Mohamed Ahmed El-Mokhtar; Abdel Rahman M M Abdel Kader; Ahmad M Mandour; Mahmoud Elhady M Mounib
Journal:  Parasitol Res       Date:  2017-07-01       Impact factor: 2.289

4.  Annual burden of ocular toxoplasmosis in the US.

Authors:  Jeffrey L Jones; Gary N Holland
Journal:  Am J Trop Med Hyg       Date:  2010-03       Impact factor: 2.345

5.  Isolation and molecular characterization of Toxoplasma gondii strains from different hosts in Iran.

Authors:  N Zia-Ali; A Fazaeli; M Khoramizadeh; D Ajzenberg; M Dardé; H Keshavarz-Valian
Journal:  Parasitol Res       Date:  2007-02-27       Impact factor: 2.289

Review 6.  Toxoplasma gondii effectors are master regulators of the inflammatory response.

Authors:  Mariane B Melo; Kirk D C Jensen; Jeroen P J Saeij
Journal:  Trends Parasitol       Date:  2011-09-03

7.  Molecular markers of susceptibility to ocular toxoplasmosis, host and guest behaving badly.

Authors:  Adriana Lima Vallochi; Anna Carla Goldberg; Angela Falcai; Rajendranath Ramasawmy; Jorge Kalil; Cláudio Silveira; Rubens Belfort; Luiz Vicente Rizzo
Journal:  Clin Ophthalmol       Date:  2008-12

8.  Analysis of Toxoplasma gondii surface antigen 2 gene (SAG2). Relevance of genotype I in clinical toxoplasmosis.

Authors:  Valeria Sabaj; Mario Galindo; Daniela Silva; Lea Sandoval; Juan C Rodríguez
Journal:  Mol Biol Rep       Date:  2009-10-20       Impact factor: 2.316

9.  The association between Toxoplasma gondii infection and hypertensive disorders in T2DM patients: a case-control study in the Han Chinese population.

Authors:  Yajing Han; Lihong Nie; Xiaohong Ye; Zixing Zhou; Shiqi Huang; Chengli Zeng; Congcong Guo; Meiling Ou; Di Xiao; Baohuan Zhang; Chuican Huang; Xingguang Ye; Chunxia Jing; Guang Yang
Journal:  Parasitol Res       Date:  2018-01-18       Impact factor: 2.289

10.  Maternal serologic screening to prevent congenital toxoplasmosis: a decision-analytic economic model.

Authors:  Eileen Stillwaggon; Christopher S Carrier; Mari Sautter; Rima McLeod
Journal:  PLoS Negl Trop Dis       Date:  2011-09-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.